https://www.selleckchem.com/products/jph203.html
With patient characteristics and T scores as covariates, an analysis of variance was performed to identify intergroup differences in changes of all outcome measures at T and T . According to the definitions of both the AWGS and EWGSOP, patients with class I and class II sarcopenia exhibited minor changes in TUGT, GS, TCR, and WOMAC-PF at T and T (all 0.05), compared with those without sarcopenia. For patients classified as having sarcopenia based on AWGS and EWGSOP definitions, no significant intergroup differences in WOMAC pain sc